Details for New Drug Application (NDA): 085603
✉ Email this page to a colleague
NDA 085603 describes TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE profile page.
The generic ingredient in TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
The generic ingredient in TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
Summary for 085603
| Tradename: | TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE |
| Applicant: | Watson Labs |
| Ingredient: | estradiol cypionate; testosterone cypionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML;50MG/ML | ||||
| Approval Date: | Mar 13, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
